Dual Antiplatelet Therapy and Outcomes in Acute Mild to Moderate Stroke With Versus Without Large‐Artery Atherosclerosis Post Hoc Analysis of ATAMIS

We conducted a post hoc analysis of the ATAMIS (Antiplatelet Therapy in Acute Mild to Moderate Ischemic Stroke) trial to investigate whether the priority of clopidogrel plus aspirin to aspirin alone was consistent between patients with and without stroke pathogenesis of large-artery atherosclerosis (LAA).